Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A L Harris

Showing results (101-110 of 682) with videos related to

Pageof 69
Sort By:
British Medical Journal (Clinical Research Ed.)|June 5, 1982
Tamoxifen-induced tumour regression associated with dermatomyositisA L Harris, I E Smith, M Snaith
Biochimica Et Biophysica Acta|June 14, 1995
Horizontal 'solvent-free' lipid bimolecular membranes with two-sided access can be formed and facilitate ion channel reconstitutionR A Brutyan, C DeMaria, A L Harris
BMJ (Clinical Research Ed.)|February 16, 1991
Convulsions and transient cortical blindness after cisplatinP A Philip, J Carmichael, A L Harris
British Journal of Haematology|May 1, 1986
Melphalan resistance in myelomaA Hall, S J Proctor, A L Harris
European Journal of Cancer & Clinical Oncology|February 1, 1986
False-positive ketonuria during ifosfamide and mesna therapyB M Cantwell, J Pooley, A L Harris
British Journal of Cancer|October 1, 1991
Phorbol ester and bryostatin effects on growth and the expression of oestrogen responsive and TGF-beta 1 genes in breast tumour cellsJ E Nutt, A L Harris, J Lunec
Biochemical Pharmacology|June 1, 1988
Adenosine-diphosphoribosyltransferase inhibitors can protect against or potentiate the cytotoxicity of S-phase acting drugsK Moses, A L Harris, B W Durkacz
Burns : Journal of the International Society for Burn Injuries|March 31, 2015
Cooling of burns: Mechanisms and modelsE H Wright, A L Harris, D Furniss
Histopathology|March 21, 2002
Ways of escape: are all tumours angiogenic?F Pezzella, A L Harris, K C Gatter
The Lancet. Oncology|March 22, 2002
Angiogenesis: pathological, prognostic, and growth-factor pathways and their link to trial design and anticancer drugsS B Fox, G Gasparini, A L Harris
Pageof 69

Showing results (101-110 of 682) with videos related to

Sort By:
Pageof 69
British Medical Journal (Clinical Research Ed.)|June 5, 1982
Tamoxifen-induced tumour regression associated with dermatomyositisA L Harris, I E Smith, M Snaith
Biochimica Et Biophysica Acta|June 14, 1995
Horizontal 'solvent-free' lipid bimolecular membranes with two-sided access can be formed and facilitate ion channel reconstitutionR A Brutyan, C DeMaria, A L Harris
BMJ (Clinical Research Ed.)|February 16, 1991
Convulsions and transient cortical blindness after cisplatinP A Philip, J Carmichael, A L Harris
British Journal of Haematology|May 1, 1986
Melphalan resistance in myelomaA Hall, S J Proctor, A L Harris
European Journal of Cancer & Clinical Oncology|February 1, 1986
False-positive ketonuria during ifosfamide and mesna therapyB M Cantwell, J Pooley, A L Harris
British Journal of Cancer|October 1, 1991
Phorbol ester and bryostatin effects on growth and the expression of oestrogen responsive and TGF-beta 1 genes in breast tumour cellsJ E Nutt, A L Harris, J Lunec
Biochemical Pharmacology|June 1, 1988
Adenosine-diphosphoribosyltransferase inhibitors can protect against or potentiate the cytotoxicity of S-phase acting drugsK Moses, A L Harris, B W Durkacz
Burns : Journal of the International Society for Burn Injuries|March 31, 2015
Cooling of burns: Mechanisms and modelsE H Wright, A L Harris, D Furniss
Histopathology|March 21, 2002
Ways of escape: are all tumours angiogenic?F Pezzella, A L Harris, K C Gatter
The Lancet. Oncology|March 22, 2002
Angiogenesis: pathological, prognostic, and growth-factor pathways and their link to trial design and anticancer drugsS B Fox, G Gasparini, A L Harris
Pageof 69